Nurix Therapeutics, Inc. (NRIX) › Shareholders' EquityNurix Therapeutics, Inc. (NRIX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2018: -$36.85M2019: -$57.71M2020: $290.27M2021: $342.30M2022: $303.70M2023: $200.49M2024: $526.99M2025: $538.75M$538.75M2018Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$538.75M+2.2%2024$526.99M+162.8%2023$200.49M-34.0%2022$303.70M-11.3%2021$342.30M+17.9%2020$290.27M+602.9%2019-$57.71M-56.6%2018-$36.85M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share